Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Neuropathy of nitroimidazole radiosensitizers: clinical and pathological description

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

The dose limiting toxicity of the nitroimidazole radiosensitizers is peripherial neuropathy. Improved pharmacology of newer drugs has eliminated the encephalopathy. Peripheral neuropathies are predominently mild to moderate paresthesias of both hands and feet. Subjective changes occur with or without minimal objective changes on neurologic exam. All of the neuropathies occurred within 30 days of the last drug dose and are of varible duration. Sural nerve biopsies from patients indicate progressive axonal degeneration affecting both large and small caliber myelinated fibers. Axonal damage appears to be more severe in the distal portion of the nerves. More data are needed for correlation of clinical and pathological changes.

Research Organization:
Washington Univ. School of Medicine, St. Louis, MO
OSTI ID:
6003812
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:9; ISSN IOBPD
Country of Publication:
United States
Language:
English